Alpine Global Management’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Alpine Global Management’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100,000	Closed	-$2.61M	–	126
2019 Q1	$2.61M	Buy	+100,000	New	+$1.87M	0.75%	19

Alpine Global Management's CMTA Position: Q2 2019 in Review

Alpine Global Management sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 100,000 shares — an estimated $2.61M sold.

Alpine Global Management first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $2.61M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Alpine Global Management reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Alpine Global Management sold 100,000 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $2.61M.
Alpine Global Management first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
Alpine Global Management's Clementia Pharmaceuticals Inc. position peaked at $2.61M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Alpine Global Management's 13F filing for Q2 2019, filed 12 Jul 2019.